Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial

International Budenofalk Study Group, A. Dignass, Juris Pokrotnieks, J. Derova (Member of the Working Group), A. Derovs (Member of the Working Group)

Research output: Contribution to journal › Article › peer-review

35 Citations (Scopus)
34 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science